Articles by John A. Wagner (4)

Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

Larissa A. Wenning, Evan J. Friedman, James T. Kost, Sheila A. Breidinger, Jon E. Stek, Kenneth C. Lasseter, Keith M. Gottesdiener, Joshua Chen, Hedy Teppler, John A. Wagner, Julie A. Stone and Marian Iwamoto

Antimicrobial Agents and Chemotherapy 52 ( 9 ): 3253 - 3258 , 2008

Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects

Matt S. Anderson, Thomas N. Kakuda, William Hanley, Jutta Miller, James T. Kost, Randall Stoltz, Larissa A. Wenning, Julie A. Stone, Richard M. W. Hoetelmans, John A. Wagner and Marian Iwamoto

Antimicrobial Agents and Chemotherapy 52 ( 12 ): 4228 - 4232 , 2008

Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir

Marian Iwamoto, Larissa A. Wenning, Amelia S. Petry, Martine Laethem, Marina De Smet, James T. Kost, Sheila A. Breidinger, Eric C. Mangin, Neal Azrolan, Howard E. Greenberg, Wouter Haazen, Julie A. Stone, Keith M. Gottesdiener and John A. Wagner

Antimicrobial Agents and Chemotherapy 52 ( 12 ): 4338 - 4343 , 2008

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

Eseng Lai, M. Gerard Waters, James R. Tata, Waldemar Radziszewski, Inna Perevozskaya, Wei Zheng, Larissa Wenning, Daniel T. Connolly, Graeme Semple, Amy O. Johnson-Levonas, John A. Wagner, Yale Mitchel and John F. Paolini

Journal of Clinical Lipidology 2 ( 5 ): 375 - 383 , 2008